yahoo finance

Dr. Reddy’s Rolls Out Remdesivir For Covid-19 Treatment In India

Dr. Reddy’s Laboratories along with its subsidiaries announced the launch of Gilead Sciences coronavirus drug candidate remdesivir under the brand name Redyx in …

Baidu In Talks With Investors To Gear Up $2B For BioTech Startup – Report

Chinese tech giant Baidu (BIDU) is gearing up investors for a $2 billion fund-raising over three years for a biotech startup, which will …

India’s Reliance Scores $1.02B Retail Investment From Silver Lake

Reliance Industries announced Wednesday that US private equity firm Silver Lake will invest $1.02 billion into its retail unit Reliance Retail Ventures Ltd.

Boeing Wins First 737 MAX Order This Year As Cancellations Continue To Hit

Boeing scored its first 737 jet order this year, while cancellations for the grounded aircraft continue as travel restrictions tied to the coronavirus …

Microsoft Joins Forces With Nutanix On Hybrid Cloud Solution

Microsoft and cloud service provider Nutanix are teaming up to roll out a hybrid cloud solution for a single software stack with seamless …

GM Snaps Up 11% Nikola Stake In Electric Trucks Partnership; Shares Soar

Investors rushed to pile up on Nikola shares as the company teamed up with General Motors to build electric pickup trucks and fuel cell …

Tuesday’s Market Snapshot: Here’s What You Need To Know Right Now

US equity indexes are declining on Tuesday as investors are continuing to dump technology stocks after the long Labor Day holiday weekend and …

Mylan To Snap Up Aspen’s Thrombosis Unit For $757M As Street Is Bullish

Mylan has entered into an agreement to buy the rights to Aspen Pharmacare’s thrombosis business in Europe for EUR 641.9 million ($756.

Beyond Meat To Build Production Facilities Close To Shanghai In China Push

Beyond Meat on Tuesday announced plans to build 2 production facilities near Shanghai as the plant-based meat pioneer has earmarked China as one …

J&J Gets European Nod For Expanded Blood Cancer Treatment

Johnson & Johnson announced Tuesday that the European Commission (EC) has approved an extended use of imbruvica (ibrutinib) in combination with rituximab for …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts